TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | -64.3% | 277 | -67.5% | 0.00% | -66.7% |
| Q2 2021 | $14,000 | -26.3% | 852 | -19.4% | 0.00% | -25.0% |
| Q1 2021 | $19,000 | 0.0% | 1,057 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $19,000 | -24.0% | 1,057 | -23.5% | 0.00% | -42.9% |
| Q3 2020 | $25,000 | -13.8% | 1,381 | -15.2% | 0.01% | -30.0% |
| Q2 2020 | $29,000 | +11.5% | 1,628 | -3.7% | 0.01% | -9.1% |
| Q1 2020 | $26,000 | -46.9% | 1,691 | -32.5% | 0.01% | -8.3% |
| Q4 2019 | $49,000 | +1125.0% | 2,506 | +948.5% | 0.01% | +500.0% |
| Q3 2019 | $4,000 | -91.3% | 239 | -90.8% | 0.00% | -90.0% |
| Q2 2019 | $46,000 | – | 2,611 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |